DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 26 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $242,004 | -1.9% | 93,800 | +64.3% | 0.00% | – |
| Q2 2023 | $246,672 | +181.9% | 57,100 | -0.2% | 0.00% | – |
| Q1 2023 | $87,498 | +0.3% | 57,188 | +3.6% | 0.00% | – |
| Q4 2022 | $87,223 | +32.2% | 55,201 | +4.1% | 0.00% | – |
| Q3 2022 | $66,000 | -31.2% | 53,007 | +10.9% | 0.00% | – |
| Q2 2022 | $96,000 | +14.3% | 47,800 | +43.0% | 0.00% | – |
| Q1 2022 | $84,000 | -5.6% | 33,423 | +39.8% | 0.00% | – |
| Q4 2021 | $89,000 | +93.5% | 23,900 | +109.6% | 0.00% | – |
| Q3 2021 | $46,000 | -56.2% | 11,400 | -51.8% | 0.00% | – |
| Q2 2021 | $105,000 | -41.0% | 23,627 | +21.6% | 0.00% | – |
| Q1 2021 | $178,000 | -15.2% | 19,425 | -6.0% | 0.00% | – |
| Q4 2020 | $210,000 | +452.6% | 20,660 | +127.0% | 0.00% | – |
| Q3 2020 | $38,000 | -7.3% | 9,100 | +56.9% | 0.00% | – |
| Q2 2020 | $41,000 | – | 5,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |